Cravens & Co Advisors, LLC
- SEC CIK
- 0001966116
- Latest filing
- Aug 12, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Cravens & Co Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,640
- Value
- $1.31M
- % of portfolio
- 0.9%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,640 | $1.31M | 0.9% | −564−17.6% | Reduced | Holders |
| Q1 2026 | 3,204 | $1.43M | 0.9% | +407+14.6% | Added | Holders |
| Q4 2025 | 2,797 | $1.27M | 0.8% | −480−14.6% | Reduced | Holders |
| Q3 2025 | 3,277 | $1.28M | 0.9% | +1,036+46.2% | Added | Holders |
| Q2 2025 | 2,241 | $997.7K | 0.7% | +63+2.9% | Added | Holders |
| Q1 2025 | 2,178 | $1.06M | 0.8% | +16+0.7% | Added | Holders |
| Q4 2024 | 2,162 | $870.6K | 0.7% | −46−2.1% | Reduced | Holders |
| Q3 2024 | 2,208 | $1.03M | 0.8% | −68−3.0% | Reduced | Holders |
| Q2 2024 | 2,276 | $1.07M | 0.8% | +2,276 | New | Holders |